Curtiss-Wright Awarded Contract By Lockheed Martin To Provide COTS Technology To Upgrade F-22s

Curtiss-Wright Corp. (CW) announced Wednesday that it was awarded a contract by Lockheed Martin Aeronautics, a Lockheed Martin Corp. (LMT) company, to provide its rugged commercial-off-the-shelf (COTS) processor module technology to upgrade the F-22 Raptor, the world's preeminent tactical fighter aircraft.

Curtiss-Wright is manufacturing the products covered by this agreement in the U.S. and is shipping them to Lockheed Martin Aeronautics. Shipments began in the fourth quarter of 2020, and are scheduled to run through 2023.

The selection of Curtiss-Wright's COTS technology is in alignment with the U.S. Air Force's (USAF) Digital Trinity for e-systems - digital engineering, agile software development and open architecture.

The use of these U.S.-built open standards-based COTS processing modules and commercial best practices will deliver cost-effective new capabilities to the USAF sooner and more affordably.

Curtiss-Wright's open standards-based processor card is the first COTS module to be selected for service onboard the F-22. The module will be used in support of the F-22 Tactical Mandates program to upgrade the aircraft's Central Integrated Processor (CIP).

The CIP provides data and signal processing for the F-22's radar, sensors, electronic warfare, and other compute intensive capabilities. This open standards approach will also enable more economical and timely upgrades of the aircraft's avionics systems.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The 737 MAX 10, Boeing Co.'s largest 737 Max model, is taking its maiden flight today, reports said citing people familiar with the matter. The flight after months of testing and certification will be around 10 a.m. local time from the Seattle area. The schedule could change depending on weather or other factors. Meanwhile, the jetliner is expected to enter commercial service in 2023. Medical devices supplier Smiths Medical, affiliated to Smiths Group plc, is recalling certain Jelco Hypodermic Needle-Pro Fixed Needle insulin syringes with skewed graduation markings, the U.S. Food and Drug Administration said. The recall was initiated after the company became aware of specific models and lots of Jelco insulin syringes that may exhibit skewed odd number line graduation markings. Saliva-based COVID-19 testing is rolled out as a pilot for public schools in New York City. The new two-month pilot program is being implemented in about 50 New York City public schools and utilizes Fluidigm Technology to offer RT-PCR COVID-19 testing. New York City public schools have instituted mandatory random weekly testing in all reopened school buildings to ensure safer in-person learning.
Follow RTT